Anders K.
- Country
- Sweden
- Department
- Ögon och Syn
Research Overview
- Evaluation of CellThRPE1 in Patients with Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
- Evaluation of the Safety and Efficacy of Subretinal CPK850 Gene Therapy in Patients with RLBP1-Associated Retinitis Pigmentosa
- Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies
Data & Insights
Has run more than one trial at 39 of 62 partner sites.
Specializations
Retinal Disorders
The investigator specializes in treating advanced ocular conditions, with particular emphasis on age-related macular degeneration (AMD) and its complications, specifically geographic atrophy (GA).
- Geographic Atrophy Management
- AMD Treatment Innovation
- Intravitreal Therapeutics
Their research extends to evaluating novel therapeutic approaches for GA lesion progression and long-term ocular health maintenance.
Genetic Eye Diseases
The investigator focuses on inherited retinal conditions, particularly retinitis pigmentosa with specific attention to cases caused by RLBP1 gene mutations.
- Gene Therapy Applications
- Subretinal Treatment Delivery
- Hereditary Retinal Disease Management
Their work encompasses evaluation of rod system recovery and retinal function restoration through targeted genetic interventions.
Clinical Assessment
The investigator employs comprehensive diagnostic approaches including optical coherence tomography and specialized vision testing methodologies.
- Visual Function Assessment
- Dark Adaptation Testing
- Ocular Imaging Technologies
Their expertise includes detailed evaluation of visual acuity, intraocular pressure, and retinal imaging analysis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.